Translational Research
Volume 156, Issue 2 , Pages 80-90 , August 2010

Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78

  • Jyh-Chang Hwang

      Affiliations

    • Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
    • ,
  • Li-Chien Chang

      Affiliations

    • School of Pharmacy, National Defense Medical Center, Taipei, Taiwan
    • ,
  • Yuh-Feng Lin

      Affiliations

    • Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
    • ,
  • Hao-Ai Shui

      Affiliations

    • Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
    • ,
  • Jin-Shuen Chen

      Affiliations

    • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan
    • Corresponding Author InformationReprint requests: Jin-Shuen Chen, Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, 325, Sec. 2, Cheng-Kung Rd., Neihu 114, Taipei, Taiwan, Republic of China

Received 29 January 2010 ,Revised 4 May 2010 ,Accepted 23 May 2010.

References 

  1. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195–207
  2. Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med. 2008;233:4–11
  3. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005;16:S30–S33
  4. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev. 1998;78:723–744
  5. Ueta M, Wakisaka M, Ago T, et al. PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose. Kidney Int. 2004;65:961–971
  6. Khwaja A, Sharpe CC, Noor M, Hendry BM. The role of geranylgeranylated proteins in human mesangial cell proliferation. Kidney Int. 2006;70:1296–1304
  7. Carpenter CL. Actin cytoskeleton and cell signaling. Crit Care Med. 2000;28:N94–N99
  8. Du H, Wang X, Wu J, Qian Q. Phenylephrine induces elevated RhoA activation and smooth muscle alpha-actin expression in Pkd2+/- vascular smooth muscle cells. Hypertens Res. 2010;33:37–42
  9. Chen JS, Lee HS, Jin JS, et al. Attenuation of mouse mesangial cell contractility by high glucose and mannitol: involvement of protein kinase C and focal adhesion kinase. J Biomed Sci. 2004;11:142–151
  10. Raiteri M, Arnaboldi L, McGeady P, et al. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation. J Pharmacol Exp Ther. 1997;281:1144–1153
  11. Rolfe BE, Worth NF, World CJ, Campbell JH, Campbell GR. Rho and vascular disease. Atherosclerosis. 2005;183:1–16
  12. Song CY, Kim BC, Lee HS. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-β1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells. Transl Res. 2008;151:27–35
  13. Calabrò P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol. 2005;20:541–546
  14. Heusinger-Ribeiro J, Fischer B, Goppelt-Struebe M. Differential effects of simvastatin on mesangial cells. Kidney Int. 2004;66:187–195
  15. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol. 2006;17:2006–2016
  16. Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant. 2003;18:265–272
  17. Ota T, Takamura T, Ando H, Nohara E, Yamashita H, Kobayashi K. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia. 2003;46:843–851
  18. Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW. Simvastatin improves diabetes-induced coronary endothelial dysfunction. J Pharmacol Exp Ther. 2006;319:386–395
  19. Nagasawa K, Muraki Y, Matsuda T, Ohnishi N, Yokoyama T. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics. J Pharm Sci. 2000;89:1594–1604
  20. Kuncewicz T, Sheta EA, Goldknopf IL, Kone BC. Proteomic analysis of S-nitrosylated proteins in mesangial cells. Mol Cell Proteomics. 2003;2:156–163
  21. Barati MT, Rane MJ, Klein JB, McLeish KR. A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells. J Proteome Res. 2006;5:1636–1646
  22. Singh LP, Jiang Y, Cheng DW. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells. Int J Biol Sci. 2006;3:27–39
  23. Wade RH, Garcia-Saez I, Kozielski F. Structural variations in protein superfamilies: actin and tubulin. Mol Biotechnol. 2009;42:49–60
  24. Walss-Bass C, Kreisberg JI, Ludueña RF. Mechanism of localization of betaII-tubulin in the nuclei of cultured rat kidney mesangial cells. Cell Motil Cytoskeleton. 2001;49:208–217
  25. Szucsik JC, Lessard JL. Cloning and sequence analysis of the mouse smooth muscle gamma-enteric actin gene. Genomics. 1995;28:154–162
  26. Clarkson MR, Murphy M, Gupta S, et al. High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. J Biol Chem. 2002;277:9707–9712
  27. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci. 2001;26:504–510
  28. Beck FX, Neuhofer W, Müller E. Molecular chaperones in the kidney: distribution, putative roles, and regulation. Am J Physiol Renal Physiol. 2000;279:F203–F215
  29. Pappenberger G, McCormack EA, Willison KR. Quantitative actin folding reactions using yeast CCT purified via an internal tag in the CCT3/gamma subunit. J Mol Biol. 2006;360:484–496

 Supported by grants from the National Defense Medical Center, the Tri-Service General Hospital (TSGH-C95-9-S02, TSGH-C96-5-S02, TSGH-C97-10-S02), and the Chi Mei Medical Center (NDMCCM9513, CMNDMC9626).

PII: S1931-5244(10)00099-X

doi: 10.1016/j.trsl.2010.05.006

Translational Research
Volume 156, Issue 2 , Pages 80-90 , August 2010

Article Tools

* Image Usage & Resolution